| Literature DB >> 15203211 |
Hideki Sano1, Scott D Feighner, Donna L Hreniuk, Hisashi Iwaasa, Andreas W Sailer, Jie Pan, Marc L Reitman, Akio Kanatani, Andrew D Howard, Carina P Tan.
Abstract
In mammals, bombesin-like peptides mediate a broad range of physiological functions through binding to three highly conserved G-protein-coupled receptors: the neuromedin B-preferring, the gastrin-releasing peptide-preferring, and the bombesin-receptor subtype 3. Selective modulation of these receptors presents opportunities for the development of novel therapeutics. To ascertain if rhesus monkey could serve as a surrogate animal model for the development of modulators of bombesin-like receptor function, we undertook a search for additional receptor family members and studied the expression profiles of the three known bombesin-related receptors. We found no evidence for additional receptor family members in mammals, suggesting that the expression of the previously described bombesin-receptor subtype 4 is limited to amphibians. We studied the distribution of the three receptors in a broad array of human and rhesus monkey tissues. Based on the similarity between the human and the rhesus expression profiles, we conclude that the rhesus monkey may be a suitable animal model to evaluate the clinical efficacy and potential side effects of bombesin-like peptide ligands. Copyright 2004 Elsevier Inc.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15203211 DOI: 10.1016/j.ygeno.2004.01.008
Source DB: PubMed Journal: Genomics ISSN: 0888-7543 Impact factor: 5.736